A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...
Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...
Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.
Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents ...
Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...
The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...